Home
About Us
Who we are
Founders and Chairs
Individual Members
Emeritus Members
Corporate and Research Members
Cambridge Angels Team
Infographic
Entrepreneurs
Why Cambridge Angels?
Is Angel Investing right for you?
Investment Criteria
Application Process
Apply
Angels
Membership Information
Member portal
Angel Interviews
Portfolio
Current Portfolio
Exits
Cambridge Angels Founded Companies
Portfolio facts
Portfolio Interviews
Apply to Cambridge Angels
News
Portfolio News
Ecosystem News

Welcome to the Cambridge Angels

Home
About Us
Who we are
Founders and Chairs
Individual Members
Emeritus Members
Corporate and Research Members
Cambridge Angels Team
Infographic
Entrepreneurs
Why Cambridge Angels?
Is Angel Investing right for you?
Investment Criteria
Application Process
Apply
Angels
Membership Information
Member portal
Angel Interviews
Portfolio
Current Portfolio
Exits
Cambridge Angels Founded Companies
Portfolio facts
Portfolio Interviews
Apply to Cambridge Angels
News
Portfolio News
Ecosystem News
Eye drops for retinal vascular diseases to be developed by Exonate and Jannssen
24 January 2020
Cambridge Angels
Eye drops for retinal vascular diseases to be developed by Exonate and Jannssen
Cambridge Angels
24 January 2020

Eye drops for retinal vascular diseases to be developed by Exonate and Jannssen

Cambridge Angels
24 January 2020

Source:https://www.cambridgeindependent.co.uk/business/eye-drops-for-retinal-vascular-diseases-to-be-developed-by-exonate-and-jannssen-9096799/

Newer PostBiofuels company appoints new chief executive
Older PostExonate Announces Collaboration With Janssen
LI-In-Bug_small.png
Back to Top
Privacy
info@cambridgeangels.net